63 related articles for article (PubMed ID: 35406808)
1. Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex.
Lemkul JA; Lewis SN; Bassaganya-Riera J; Bevan DR
PLoS One; 2015; 10(5):e0123984. PubMed ID: 25954810
[TBL] [Abstract][Full Text] [Related]
2. Molecular determinants of magnolol targeting both RXRα and PPARγ.
Zhang H; Xu X; Chen L; Chen J; Hu L; Jiang H; Shen X
PLoS One; 2011; 6(11):e28253. PubMed ID: 22140563
[TBL] [Abstract][Full Text] [Related]
3. Binding of Per- and Polyfluoroalkyl Substances (PFAS) to the PPARγ/RXRα-DNA Complex.
Almeida NMS; Bali SK; James D; Wang C; Wilson AK
J Chem Inf Model; 2023 Dec; 63(23):7423-7443. PubMed ID: 37990410
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry-based FRET identifies binding intensities in PPARγ1 protein-protein interactions in living cells.
Trümper V; von Knethen A; Preuß A; Ermilov E; Hackbarth S; Kuchler L; Gunne S; Schäfer A; Bornhütter T; Vereb G; Ujlaky-Nagy L; Brüne B; Röder B; Schindler M; Parnham MJ; Knape T
Theranostics; 2019; 9(19):5444-5463. PubMed ID: 31534496
[TBL] [Abstract][Full Text] [Related]
5. Quantification of Cooperativity in Heterodimer-DNA Binding Improves the Accuracy of Binding Specificity Models.
Isakova A; Berset Y; Hatzimanikatis V; Deplancke B
J Biol Chem; 2016 May; 291(19):10293-306. PubMed ID: 26912662
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic Localization of Thyroid Hormone Receptor (TR) Alpha and Nuclear Expression of Its Isoform TRα2 Determine Survival in Breast Cancer in Opposite Ways.
Schneider M; Köpke MB; Zehni AZ; Vilsmaier T; Kessler M; Kailuweit M; Vattai A; Heidegger HH; Cavaillès V; Jeschke U; Ditsch N
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509273
[TBL] [Abstract][Full Text] [Related]
7. Retinoic Acid and Retinoid X Receptors.
Schubert M; Germain P
Cells; 2023 Mar; 12(6):. PubMed ID: 36980205
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Relevance of Nuclear Receptors in Relation to Peritumoral Inflammation and Tumor Infiltration by Lymphocytes in Breast Cancer.
Köpke MB; Chateau MC; Boissière-Michot F; Schneider M; Garrido F; Zati-Zehni A; Vilsmaier T; Kessler M; Ditsch N; Cavaillès V; Jeschke U
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230483
[TBL] [Abstract][Full Text] [Related]
9. Protein Profiling of Breast Carcinomas Reveals Expression of Immune-Suppressive Factors and Signatures Relevant for Patient Outcome.
Ruoff F; Kersten N; Anderle N; Jerbi S; Stahl A; Koch A; Staebler A; Hartkopf A; Brucker SY; Hahn M; Schenke-Layland K; Schmees C; Templin MF
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139700
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers.
Shao W; Kuhn C; Mayr D; Ditsch N; Kailuwait M; Wolf V; Harbeck N; Mahner S; Jeschke U; Cavaillès V; Sixou S
J Transl Med; 2020 Feb; 18(1):94. PubMed ID: 32085795
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the nongenomic actions of retinoid X receptor-α by targeting the coregulator-binding sites.
Zhang XK; Su Y; Chen L; Chen F; Liu J; Zhou H
Acta Pharmacol Sin; 2015 Jan; 36(1):102-12. PubMed ID: 25434990
[TBL] [Abstract][Full Text] [Related]
12. Understanding nuclear receptor form and function using structural biology.
Rastinejad F; Huang P; Chandra V; Khorasanizadeh S
J Mol Endocrinol; 2013 Dec; 51(3):T1-T21. PubMed ID: 24103914
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic Colocalization of RXRα and PPARγ as an Independent Negative Prognosticator for Breast Cancer Patients.
Shao W; Köpke MB; Vilsmaier T; Zati Zehni A; Kessler M; Sixou S; Schneider M; Ditsch N; Cavaillès V; Jeschke U
Cells; 2022 Apr; 11(7):. PubMed ID: 35406808
[TBL] [Abstract][Full Text] [Related]
14. Heterodimer formation with retinoic acid receptor RXRα modulates coactivator recruitment by peroxisome proliferator-activated receptor PPARγ.
Kilu W; Merk D; Steinhilber D; Proschak E; Heering J
J Biol Chem; 2021 Jul; 297(1):100814. PubMed ID: 34081964
[TBL] [Abstract][Full Text] [Related]
15. Retinoid X receptor alpha (RXRα) and peroxisome proliferator-activated receptor gamma (PPARγ) expression in breast cancer: an immunohistochemical study.
Ditsch N; Vrekoussis T; Lenhard M; Rühl I; Gallwas J; Weissenbacher T; Friese K; Mayr D; Makrigiannakis A; Jeschke U
In Vivo; 2012; 26(1):87-92. PubMed ID: 22210720
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
